Role of Exosome-Mediated Gene Transfer in Lung Cancer Transfection
Exosomes are small extracellular vesicles secreted by cells that mediate intercellular communication by transferring proteins, lipids, and nucleic acids, including RNA and DNA. In lung cancer research, exosome-mediated gene transfer is an emerging area with significant implications for tumor progression, metastasis, and therapeutic delivery.
Exosomes derived from lung cancer cells can transfer oncogenic miRNAs or mRNAs to recipient cells, modulating gene expression and promoting malignant phenotypes such as drug resistance and immune evasion. Harnessing this natural delivery system, researchers are exploring exosomes as vehicles for therapeutic nucleic acid delivery, including siRNA and CRISPR components, aiming to improve targeting and reduce toxicity.
Isolation and engineering of exosomes for lung cancer transfection require advanced protocols to ensure purity, loading efficiency, and targeting specificity. Modified exosomes can be tailored to express surface ligands directing them to lung tumor cells, enhancing uptake and gene modulation.
Despite promising preclinical data, challenges include large-scale production, heterogeneity of exosome populations, and controlling off-target effects. Understanding the biology of lung cancer exosomes and refining delivery strategies will facilitate their application as novel gene transfer tools.
Exosome-mediated gene transfer offers a biomimetic and potentially less immunogenic alternative to synthetic vectors, representing a frontier in lung cancer transfection technology with therapeutic potential.
References: Altogen.com Altogenlabs.com